NumFin

Vertex Pharmaceuticals Incorporated

Symbol: VRTX

NASDAQ

400.16

USD

Markedspris i dag

  • 28.4897

    P/E-forhold

  • 1.0778

    PEG Ratio

  • 103.36B

    MRK Cap

  • 0.00%

    DIV Udbytte

Vertex Pharmaceuticals Incorporated (VRTX) Årsregnskaber

Download
ÅrligKvartalsvis
LineærLog
På diagrammet kan du se standardtallene i dynamik for Vertex Pharmaceuticals Incorporated (VRTX). Virksomhedens omsætning viser gennemsnittet af 1515.622 M, som er 0.661 % gowth. Den gennemsnitlige bruttofortjeneste for hele perioden er 1332.322 M, som er 0.555 %. Den gennemsnitlige bruttofortjeneste er 0.989 %. Væksten i nettoindkomst for virksomheden sidste år er 0.090 %, hvilket svarer til -0.366 % % i gennemsnit for hele virksomhedens historie.,

ÅrligKvartalsvis
10Y20Y30Y40Y

Balance

Når vi dykker ned i den skattemæssige udvikling for Vertex Pharmaceuticals Incorporated, ser vi en gennemsnitlig aktivvækst. Det er interessant, at denne rate ligger på , hvilket afspejler både virksomhedens op- og nedture. Når man sammenligner kvartal for kvartal, justeres dette tal til 0. Et kig tilbage på det seneste år afslører en samlet aktivændring på 0.252. Når det gælder omsætningsaktiver, er VRTX på 14144.2 i rapporteringsvalutaen. En betydelig del af disse aktiver, helt præcist 11221.5, ligger i kontanter og kortfristede investeringer. Dette segment viser en ændring på 0.041%, når det sammenlignes med sidste års data. Virksomhedens langsigtede investeringer, som ikke er dens fokus, ligger på 2596.4, hvis nogen, i rapporteringsvalutaen. Dette indikerer en forskel på 2512.072% fra den sidste rapporteringsperiode, hvilket afspejler virksomhedens strategiske skift. Virksomhedens gældsprofil viser en samlet langfristet gæld på 724.7 i rapporteringsvalutaen. Dette tal betyder en ændring fra år til år på 0.441%. Aktionærværdi, som vist ved den samlede egenkapital, er vurderet til 17580.4 i rapporteringsvalutaen. Ændringen fra år til år i dette aspekt er 0.264%. Et dybere dyk ned i virksomhedens økonomi afslører yderligere detaljer. Nettotilgodehavenderne er vurderet til 1563.4, med en værdiansættelse af varelageret på 738.8 og goodwill vurderet til 1088, hvis der er nogen. De samlede immaterielle aktiver, hvis de findes, værdiansættes til 839.9.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999199819971996199519941993199219911990

balance-sheet.row.cash-and-short-term-investments

44800.111221.510778.57524.9
6658.9
3808.3
3168.2
2088.7
1434.6
1042.5
1387.1
1465.1
1321.2
968.9
1031.4
1284.9
832.1
460.9
704.6
361.2
392.3
583.2
635
743.2
388.6
31.5
24.2
71.5
34.9
28.4
71.6
28.6
11.6
27.6
4.4

balance-sheet.row.short-term-investments

25137.9849.2274.5729.9
670.7
699
518.1
423.3
250.6
327.7
761.8
895.8
831.8
493.6
788.2
838.3
443
105.2
491.5
283.1
337.3
485
526.9
554
66.5
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.net-receivables

6206.11563.41442.21136.8
885.4
633.5
409.7
281.3
201.1
177.6
73
85.5
143.3
183.1
12.5
9.6
23.5
31.3
62.9
20.6
11.9
7.3
13.2
20.3
12.3
5.9
0
0
0
0
0
0
0
0
0

balance-sheet.row.inventory

2566.1738.8460.6353.1
280.8
167.5
124.4
111.8
77.6
56.1
30.8
14.1
30.5
112.4
0
0
0
0
0
0
0
0
4.3
6.6
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-current-assets

2106.3620.574.4187.2
308.4
213.5
74
64
16.8
12.1
57.2
23.8
24.7
983.8
13.1
12.5
12
4.7
3.9
3.3
2.5
3.3
4
6
2.3
157.8
224.5
210.1
97.3
59.5
35.3
24.5
32.4
24.1
0.2

balance-sheet.row.total-current-assets

55678.614144.212681.39014.8
7825
4609.3
3702.3
2483.3
1761
1355.1
1548.1
1588.6
1589.6
1331.3
1057
1307
867.6
496.9
771.4
385.1
406.7
593.8
656.6
776.1
403.2
195.2
248.7
281.6
132.2
87.9
106.9
53.1
44
51.7
4.6

balance-sheet.row.property-plant-equipment-net

5782.11452.91108.41094.1
958.5
745.1
812
789.4
698.4
697.7
715.8
696.9
433.6
133.2
72.3
62.3
68.3
66.5
61.5
54.5
64.2
80.1
96
80.4
28.1
24.5
14.5
11.1
8.7
7.8
8.5
7.7
6.9
5
4.4

balance-sheet.row.goodwill

4352108810881402.2
1402.2
1402.2
50.4
50.4
50.4
50.4
39.9
31
31
31
26.1
26.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

2650.7839.9603.6400
400
400
0
29
284.3
284.3
29
105.8
663.5
663.5
518.7
518.7
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.goodwill-and-intangible-assets

7002.71927.91691.61402.2
1402.2
1402.2
50.4
79.4
334.7
334.7
68.9
31
694.5
694.5
544.8
544.8
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.long-term-investments

6735.22596.499.485.8
20.8
44.2
0
20.4
20.3
0
0
7.5
0
0
0
0
0
0
0
18.9
18.9
18.9
26.4
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.tax-assets

6439.11812.11246.9934.5
882.8
1190.8
1499.7
-20.4
-20.3
0
0
-7.5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-non-current-assets

2142.1796.71323.3901.1
662.5
326.9
181.5
193.9
99.7
109.5
3.4
2.6
41.6
45.4
51.3
41.4
44.6
38.1
88.6
90.5
55.7
31.7
36.7
68.7
341.5
12.7
3.1
2.9
2.6
3.3
0.8
0.2
0.1
0.4
0.2

balance-sheet.row.total-non-current-assets

28101.285865469.64417.7
3926.8
3709.2
2543.6
1062.7
1132.8
1142
788.2
730.5
1169.7
873
668.4
648.5
112.9
104.6
150.2
163.9
138.7
130.6
159.1
149
369.7
37.2
17.6
14
11.3
11.1
9.3
7.9
7
5.4
4.6

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

83779.822730.218150.913432.5
11751.8
8318.5
6245.9
3546
2893.8
2497
2336.3
2319
2759.3
2204.3
1725.4
1955.5
980.5
601.5
921.6
549
545.5
724.4
815.7
925.1
772.9
232.4
266.3
295.6
143.5
99
116.2
61
51
57.1
9.2

balance-sheet.row.account-payables

1427364.9303.9195
155.1
87.6
111
74
61.5
74.9
71.2
49.3
101.3
74.6
35.9
37
51.8
32.8
15.4
6.2
6.7
12.3
16.7
11.6
3.8
3
2.8
4.2
1.4
3
1.4
3.5
0.7
0.8
0

balance-sheet.row.short-term-debt

83.783.789.446.9
42.4
30.3
9.8
22.5
319.4
87
32
16.9
13.7
195.4
137
32.1
105.9
20
103.8
59.6
94.7
4.7
2.2
4.6
2.4
2.4
2.8
2.5
2.9
2.1
1.7
1.8
1.8
1.2
0.8

balance-sheet.row.tax-payables

99.599.5123.3211.3
104.2
72.3
0
0
6.9
31
10
8.4
0.7
12.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.long-term-debt-total

3026.2724.7471.6556.7
581.5
577.4
567.2
563.9
838.2
820.6
825.3
440.9
672.6
400
400
153.8
287.5
0
20
180.1
335
340.7
325.9
323
347.3
4.7
7
5.9
5.6
4.9
4.7
4.2
3.3
2.1
2.4

Deferred Revenue Non Current

-924.1-924.100
0
88.8
82.6
80.2
12.6
26
45.3
71
123.8
118.1
160
38.2
247.5
101.2
116.3
0.9
18.3
51.8
46.6
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

924.1---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

11844.12928.51877.71460
1171
1024.3
40.6
473.2
-452.3
328.1
247.6
310.1
290.1
405.6
227.3
296.9
21.3
121
98
3
4.7
114.4
33.8
35.8
32.4
13.1
7.5
7
2.8
3.7
2.9
2
1.4
0.7
0.8

balance-sheet.row.total-non-current-liabilities

62591602.41807.61458.9
1504.9
1028.7
1095.2
1503.7
1547.6
1404.4
1240.1
962.6
1524.9
400
746.7
192
525
130.9
164.6
209.6
356.3
392.5
372.5
358.2
347.3
4.7
7
5.9
5.6
4.9
4.7
4.2
3.2
2.2
2.4

balance-sheet.row.other-liabilities

0000
0
0
0
-807.3
0
-506.3
-368.3
-397.8
-432.6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

3026.2724.7471.6556.7
581.5
577.4
567.2
563.9
541.3
525.2
530.5
440.9
272.6
0
0
32.1
0
0
0
0
0
25.7
10.9
8
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

19784.15149.84238.23332.5
3065
2233.2
1810.7
1503.7
1555.6
1404.4
1240.1
962.6
1524.9
1238.8
1221.5
858.5
741.6
330.2
415.6
309.8
510
531.6
437.1
449.8
386
23.2
20.1
19.6
12.7
13.7
10.7
11.5
7.1
4.9
4

balance-sheet.row.preferred-stock

0000
0
0
0
13.7
181.6
152.7
21.2
0
0
0
0
0.6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

520.82.62.62.5
2.6
2.6
2.5
2.5
2.5
2.4
2.4
2.3
2.1
2.1
2
2
1.5
1.3
1.2
1.1
0.8
0.8
0.8
0.8
0.6
0.3
0
0
0
0
0
0
0
0
0

balance-sheet.row.retained-earnings

34676.910142.46522.83200.8
858.7
-1853
-2989.5
-5119.7
-5373.8
-5261.8
-4705.4
-3966.9
-3521.9
-3414.8
-3444.4
-2689.8
-2047.6
-1587.8
-1196.5
-989.6
-786.2
-619.9
-423.2
-314.5
-230.5
-190.8
-149.9
-116.8
-96.9
-56.9
-35.4
-17.8
-19.9
-11.4
-6.2

balance-sheet.row.accumulated-other-comprehensive-income-loss

-70.2-14.30.815.9
-68.5
-2
0.7
-11.6
21.2
1.8
0.9
-0.3
-0.6
-1.1
-1.1
-0.6
3.2
0.9
-1
-16.3
-13
1.6
6.8
11.1
3.6
-1.1
-28.1
-23.6
-20
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

28868.27449.77386.56880.8
7894
7937.6
7421.5
7157.4
6506.8
6197.5
5777.2
5321.3
4519.4
4200.7
3947.4
3784.8
2281.8
1856.9
1702.1
1244
833.8
810.4
794.2
858
659.4
434.1
424.2
416.4
247.7
142.2
140.9
67.3
63.8
63.6
11.4

balance-sheet.row.total-stockholders-equity

63995.717580.413912.710100
8686.8
6085.2
4435.2
2042.3
1338.2
1092.7
1096.2
1356.4
999.2
786.8
504
1096.9
238.9
271.3
505.9
239.2
35.4
192.8
378.6
475.4
386.9
209.2
246.2
276
130.8
85.3
105.5
49.5
43.9
52.2
5.2

balance-sheet.row.total-liabilities-and-stockholders-equity

83779.822730.218150.913432.5
11751.8
8318.5
6245.9
3546
2893.8
2497
2336.3
2319
2759.3
2204.3
1725.4
1955.5
980.5
601.5
921.6
549
545.5
724.4
815.7
925.1
772.9
232.4
266.3
295.6
143.5
99
116.2
61
51
57.1
9.2

balance-sheet.row.minority-interest

0000
0
0
0
13.7
181.6
153.7
21.2
0
235.2
178.7
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-equity

63995.717580.413912.710100
8686.8
6085.2
4435.2
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

83779.8---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

31873.13445.6274.5729.9
670.7
699
518.1
443.7
270.9
327.7
761.8
895.8
831.8
493.6
788.2
838.3
443
105.2
491.5
302
356.2
503.9
553.3
554
66.5
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-debt

3109.9808.4561556.7
581.5
577.4
567.2
563.9
838.2
820.6
825.3
440.9
672.6
400
537
153.8
287.5
20
123.8
180.1
335
345.4
328.1
327.6
349.7
7.1
9.8
8.4
8.5
7
6.4
6
5.1
3.3
3.2

balance-sheet.row.net-debt

-37813.6-9563.9-9943-6238.3
-5406.7
-2532
-2083
-1101.5
-345.7
105.8
200
-128.4
183.2
-75.3
293.8
-292.8
-101.6
-335.7
-89.4
102.1
280
247.2
220
138.4
27.6
-24.4
-14.4
-63.1
-26.4
-21.4
-65.2
-22.6
-6.5
-24.3
-1.2

Pengestrømsopgørelse

Det økonomiske landskab for Vertex Pharmaceuticals Incorporated har set en bemærkelsesværdig ændring i det frie cash flow i løbet af den sidste periode, hvilket udviser et skift på -0.165. Virksomheden udvidede for nylig sin aktiekapital ved at udstede 134.6, hvilket markerer en forskel på 0.000 i forhold til det foregående år. Virksomhedens investeringsaktiviteter resulterede i et nettokasseforbrug på -3141700000.000 i rapporteringsvalutaen. Dette er en forskydning på 8.784 fra året før. I samme periode har virksomheden registreret 181.3, 6.1 og -44.9, som er væsentlige for forståelsen af virksomhedens investerings- og afdragsstrategier. Virksomhedens finansieringsaktiviteter førte til et nettokasseforbrug på 0.000, med en forskel fra år til år på 0.000. Desuden afsatte virksomheden 0 til udbetaling af udbytte til sine aktionærer. Samtidig foretog virksomheden andre finansielle manøvrer, kaldet -224.3, som også påvirkede pengestrømmen betydeligt i denne periode. Disse komponenter tegner tilsammen et omfattende billede af virksomhedens økonomiske status og strategiske tilgang til likviditetsstyring.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997199619951994199319921991

cash-flows.row.net-income

3619.63619.633222342.1
2711.6
1176.8
2087.1
91.6
-84
-588.2
-742.7
-687.5
-51.1
41.2
-754.6
-642.2
-459.9
-391.3
-206.9
-203.4
-166.2
-196.8
-108.6
-66.2
-39.7
-41
-33.1
-19.8
-40
-21.5
-17.6
2
-8.5
-5.1

cash-flows.row.depreciation-and-amortization

181.3181.3148.3125.6
109.5
106.9
72.4
61.4
61.4
62.3
63.3
48.4
38.2
35
30.5
30.1
32.2
27.5
25.9
27.3
29.6
23.4
25.4
18
9.1
6.3
4.5
3.6
3.2
3.7
3.5
3.9
2.8
1.8

cash-flows.row.deferred-income-tax

-536.5-536.5-275.9-154.6
277.3
167.4
-1512.3
-120.5
17
3.3
0.3
-285.1
36.7
-7.5
54.9
-2.2
0
-59.1
-50.2
-7.5
-4.2
-3.1
-1.5
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

581.2581.2491.3441.4
429.5
360.5
325
290.7
237.7
231
177.5
127.3
114.3
126.8
97.7
86.7
63
59.4
39.1
7.5
4.2
3.1
1.5
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

-265.7-265.7340.8-105.2
-54.5
-66.1
238
15.3
-2.1
-86
-11.1
-5.1
-13.8
-193.1
-63.8
61.4
138.8
47.3
123.1
-52.1
-12.7
68.9
0.9
41.1
9.8
1.5
-1.9
6.9
-3.3
1.9
-0.6
2.7
0.4
0.8

cash-flows.row.account-receivables

-84.1-84.1-358.6-274.7
-223.4
-225.6
-108.2
-71.8
-33
-104.8
7.4
53.4
39.9
-170.6
-2.9
13.9
7.8
31.6
-42.3
-8.7
-4.6
1.6
13.6
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

-322.9-322.9-136.4-92.8
-132
-64
-32
-45
-16.4
-23.1
-16.5
7.1
-29.9
-111.4
6.2
9.5
-3.2
19.5
48.2
0
0
70.8
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.account-payables

48.748.7120.831.9
51.3
-22.8
36.6
8.8
-11.7
-1.7
25
-49.2
14.9
37.5
-1.2
-15.1
19
17.4
9.2
-0.5
-5.6
-2.2
3.2
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

-46.392.6715230.4
249.7
246.3
341.6
123.3
59.2
43.8
-27.1
-16.3
-38.7
51.5
-65.9
53.1
115.1
-21.2
108
-42.9
-2.5
-1.2
-16
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-non-cash-items

-42.6-42.6103.4-5.8
-220
-176.2
60
506.4
6.1
12
-0.5
750.4
143.6
141.3
0
38.6
-0.6
63.7
46.6
56.1
7.2
-63.2
2.8
-0.9
4.1
1.4
-0.6
-0.1
-0.2
-0.1
0
0
0
0

cash-flows.row.net-cash-provided-by-operating-activities

3537.3000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

-258.4-258.4-204.7-235
-259.8
-75.5
-95.5
-259.4
-56.6
-45.3
-51.2
-51.4
-71.1
-94.6
-38.1
-23.5
-32.2
-32.4
-32.4
-17
-12.5
-17.4
-41.2
-53.9
-11.9
-16.2
-7.9
-6
-4
-5.4
-1.9
-1.8
-1.5
-1.2

cash-flows.row.acquisitions-net

55.9-6.1-295.977
-418.2
-1154.2
0
-160
0
-80
-10
0
0
-60
0
-87.4
0
33
0
0
0
97.1
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.purchases-of-investments

-3848.5-3817.5-740.5-605.2
-450.7
-576.5
-515.4
-532.6
-629.7
-633
-1424.2
-2412.4
-1705.8
-721.5
-1234.7
-1186.7
-755.4
-318
-508.1
-236.5
-148.5
-555.8
-703
-1252.8
-1312.8
-366
-507.5
-303.6
-73
-61.9
-83.9
-48.3
-39.7
0

cash-flows.row.sales-maturities-of-investments

934.2934.2920499.3
809.9
570.9
431.6
369.2
757.6
1067.4
1557.9
2348.3
1367.9
1016
1284.8
788.3
427.6
755.6
302.4
243.4
292.4
594
728
1176.2
1088.6
428.9
495.3
191
36.2
38.3
72.3
56.8
31.6
-23.9

cash-flows.row.other-investing-activites

-24.96.10-77
418.2
0
-22.8
145.1
33.2
-40.2
1.4
61.4
-16.8
72.5
-4.7
0.6
-0.7
-33
29.6
8.3
-23.9
1.6
0.2
-14.6
-0.2
-10.3
-0.3
-0.2
0.4
0
-0.6
0
0.2
-0.1

cash-flows.row.net-cash-used-for-investing-activites

-3141.7-3141.7-321.1-340.9
99.4
-1235.3
-202.2
-437.7
104.5
268.9
74
-54.1
-425.8
212.4
7.3
-508.7
-360.6
405.2
-208.5
-1.7
107.4
119.6
-16
-145.1
-236.3
36.4
-20.4
-118.8
-40.4
-29
-14.1
6.7
-9.4
-25.2

cash-flows.row.debt-repayment

-44.9-44.9-85.5-47
-42.3
-39.2
-33.4
-319.3
-93
-20.3
-81.7
-83.7
-21.5
-250
0
-0.1
-20
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-issued

134.6134.6186.3102
264.9
343.2
289.3
344.8
68.2
185.6
274.6
265.9
191.7
124.9
33.4
849.2
362.1
32
366
32.2
8.7
12
13.3
19.7
42.4
5.5
2.8
164.9
85.5
1.1
73.8
3.6
0.1
51.9

cash-flows.row.common-stock-repurchased

-650.5-427.6-172-1561.3
-739.4
-192
-350
0
0
0
0
0
0
0
0
290.6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

000-102
-264.9
-10
-20.8
0
0
0
0
0
0
0
0
-290.6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-financing-activites

72.6-224.33.5130.3
276.4
24.8
43.8
42.9
158.1
23.7
304.5
-1.3
2
0.9
391.6
149.9
278.6
-42.2
-0.2
165.3
-17.4
25.5
0.5
-23.6
501.6
-2.7
1.4
-0.1
1.6
0.6
-1.9
-2
-1.3
-1

cash-flows.row.net-cash-used-provided-by-financing-activities

-562.2-562.2-67.7-1478
-505.3
126.8
-71.2
68.4
133.3
188.9
497.4
180.9
172.2
-124.2
425.1
999
620.7
-10.2
365.9
197.5
-8.6
37.5
13.8
-4
544
2.8
4.2
164.8
87.1
1.7
71.9
1.6
-1.2
50.9

cash-flows.row.effect-of-forex-changes-on-cash

26.926.9-29.2-13.4
20.6
1.6
-6.2
5.8
-4.7
-2.8
-2.2
4.7
-0.1
0.2
-0.4
-5.1
-0.2
0
0.2
-0.6
0.2
0.6
0.6
-0.3
-0.5
-0.1
51.5
128.2
80.7
45
28.8
-15.3
14.7
27.7

cash-flows.row.net-change-in-cash

-139.7-139.73711.9811.2
2868.2
462.4
990.7
481.5
469.2
89.5
56
79.9
14.1
232.1
-203.5
57.5
33.5
142.5
135.1
23
-43.2
-9.9
-81.1
-157.5
290.5
7.3
4.2
164.8
87.1
1.7
71.9
1.6
-1.2
50.9

cash-flows.row.cash-at-end-of-period

40937.910372.3105126800.1
5988.8
3120.7
2658.3
1665.4
1183.9
714.8
625.3
569.3
489.4
475.3
243.2
446.7
389.1
355.7
213.2
78
55
98.2
108.1
189.2
322.1
31.5
75.7
199.7
115.5
73.3
100.5
13.2
26.4
55.3

cash-flows.row.cash-at-beginning-of-period

41077.6105126800.15988.9
3120.7
2658.3
1667.5
1183.9
714.8
625.3
569.3
489.4
475.3
243.2
446.7
389.1
355.7
213.2
78
55
98.2
108.1
189.2
346.7
31.5
24.2
71.5
34.9
28.4
71.6
28.6
11.6
27.6
4.4

cash-flows.row.operating-cash-flow

3537.33537.34129.92643.5
3253.5
1569.3
1270.3
844.9
236.1
-365.4
-573.1
-60.7
267.8
143.7
-635.4
-427.6
-226.5
-252.5
-22.5
-172.1
-142.2
-167.6
-79.5
-8.1
-16.6
-31.8
-31.1
-9.4
-40.3
-16
-14.7
8.6
-5.3
-2.5

cash-flows.row.capital-expenditure

-258.4-258.4-204.7-235
-259.8
-75.5
-95.5
-259.4
-56.6
-45.3
-51.2
-51.4
-71.1
-94.6
-38.1
-23.5
-32.2
-32.4
-32.4
-17
-12.5
-17.4
-41.2
-53.9
-11.9
-16.2
-7.9
-6
-4
-5.4
-1.9
-1.8
-1.5
-1.2

cash-flows.row.free-cash-flow

3278.93278.93925.22408.5
2993.7
1493.9
1174.8
745.5
179.5
-410.7
-624.3
-170.5
196.7
49.1
-673.5
-451.1
-258.7
-284.9
-54.9
-189
-154.7
-185
-120.8
-62
-28.6
-48
-39
-15.4
-44.3
-21.4
-16.6
6.8
-6.8
-3.7

Resultatopgørelse række

Vertex Pharmaceuticals Incorporateds omsætning oplevede en ændring på 0.102% sammenlignet med den foregående periode. Bruttofortjenesten for VRTX rapporteres til at være 8576.8. Virksomhedens driftsomkostninger er 4826.6 og viser en ændring på 38.496% fra sidste år. Udgifterne til afskrivninger er 181.3, hvilket er en ændring på 3.796% fra sidste regnskabsperiode. Driftsudgifterne rapporteres at være 4826.6, hvilket viser en 38.496% ændring fra år til år. Salgs- og marketingomkostninger er 0, hvilket er en ændring på 0.000% sammenlignet med året før. EBITDA baseret på de seneste tal er 0, hvilket repræsenterer en -0.129% vækst i forhold til året før. Driftsindtægterne er 3750.2, som viser en ændring på -0.129% sammenlignet med året før. Ændringen i nettoindkomsten er 0.090%. Nettoindkomsten for det sidste år var 3619.6.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999199819971996199519941993199219911990

income-statement-row.row.total-revenue

9869.298398930.77574.4
6205.7
4162.8
3047.6
2488.7
1702.2
1032.3
580.4
1212
1527
1410.6
143.4
102
175.5
199
216.4
160.9
102.7
69.1
161.1
167.5
78.1
61.6
44.4
43.8
13.3
22.1
19.6
27.9
3.8
3.2
2.3

income-statement-row.row.cost-of-revenue

1262.21262.21080.3904.2
736.3
547.8
409.5
275.1
210.5
125.5
61
130.3
279.9
80.5
12.7
14.2
15.7
13.9
12.2
10.1
5.6
3.1
28.3
39.6
4.1
-3.4
-4.5
-3.6
-3.2
-3.7
-3.5
-3.9
-2.8
-1.8
0

income-statement-row.row.gross-profit

86078576.87850.46670.2
5469.4
3615.1
2638.1
2213.5
1491.7
906.8
519.4
1081.7
1247.2
1330.1
130.6
87.8
159.8
185.1
204.2
150.8
97.1
66
132.8
127.9
74
65
48.9
47.4
16.5
25.8
23.1
31.8
6.6
5
2.3

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

3160.1---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

-22.8-22.8-164.84.9
296.4
192.2
-0.8
-81.4
4.1
-6.7
30.4
-72.7
45
124.8
0
0
0
0
0
0
0
0
0
0
0
6.3
4.5
3.6
3.2
3.7
3.5
3.9
2.8
1.8
0

income-statement-row.row.operating-expenses

4296.74826.634853891.2
2600
2413
1974.1
1820.7
1480.5
1373.3
1160.9
1281.1
1243
1108.4
825.2
680
618.2
597.8
429.6
292.5
234.3
238.7
252.4
196
112.7
104.6
81.3
66.6
46.3
52.3
43.8
30.6
16.6
10.6
6.4

income-statement-row.row.cost-and-expenses

5558.96088.84565.34795.4
3336.3
2960.8
2383.6
2095.8
1691
1498.8
1221.9
1411.4
1522.9
1188.9
837.9
694.2
633.9
611.7
441.7
302.6
239.9
241.8
280.7
235.6
116.8
101.2
76.8
63
43.1
48.6
40.3
26.7
13.8
8.8
6.4

income-statement-row.row.interest-income

614.7614.7144.64.9
22.2
63.7
0
0
0
0
0
0
1.9
1.9
2
5
16.3
0
23
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.interest-expense

44.144.154.861.5
58.2
58.5
34.1
57.5
81.4
84.2
72.9
22.7
14.7
36.6
19.3
13.2
13.5
0
-8
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

124.2629.6-75-51.7
260.5
197.4
-29.6
-351
2.9
-8.9
-20.5
-776.7
-1.8
-124.7
-42.7
-49.4
-1.5
-7.1
2.4
-23.5
-3.7
-82.8
-0.1
-26.1
-14.9
-0.7
0
0
-9.7
5.5
3.6
1.4
2
0.8
0

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

-22.8-22.8-164.84.9
296.4
192.2
-0.8
-81.4
4.1
-6.7
30.4
-72.7
45
124.8
0
0
0
0
0
0
0
0
0
0
0
6.3
4.5
3.6
3.2
3.7
3.5
3.9
2.8
1.8
0

income-statement-row.row.total-operating-expenses

124.2629.6-75-51.7
260.5
197.4
-29.6
-351
2.9
-8.9
-20.5
-776.7
-1.8
-124.7
-42.7
-49.4
-1.5
-7.1
2.4
-23.5
-3.7
-82.8
-0.1
-26.1
-14.9
-0.7
0
0
-9.7
5.5
3.6
1.4
2
0.8
0

income-statement-row.row.interest-expense

44.144.154.861.5
58.2
58.5
34.1
57.5
81.4
84.2
72.9
22.7
14.7
36.6
19.3
13.2
13.5
0
-8
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.depreciation-and-amortization

989.2181.337.86.7
331.8
260.3
72.4
61.4
61.4
62.3
63.3
48.4
38.2
35
30.5
30.1
32.2
27.5
25.9
27.3
29.6
23.4
25.4
18
9.1
6.3
4.5
3.6
3.2
3.7
3.5
3.9
2.8
1.8
0

income-statement-row.row.ebitda-caps

4791.5---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

3802.33750.24307.42782.1
2856.3
1197.6
635.1
123.2
9.9
-468.7
-692.4
-903.4
2.3
113.8
-696.1
-613.4
-462.7
-419.8
-229
-149.9
-154.8
-264.5
-119.6
-91.8
-38.7
-39.6
-32.4
-19.2
-29.8
-26.5
-20.7
1.2
-10
-5.6
-4.1

income-statement-row.row.income-before-tax

4379.84379.84232.42730.4
3116.8
1394.9
600.2
-15.7
-67.4
-559.6
-734.9
-976.1
-12.4
60.4
-754.6
-642.2
-464.2
-426.9
-206.9
-173.4
-158.5
-347.3
-119.7
-117.9
-53.6
-40.3
0
0
-39.5
-21
-17.1
2.1
-8
-4.8
0

income-statement-row.row.income-tax-expense

760.2760.2910.4388.3
405.2
218.1
-1486.9
-107.3
16.7
30.4
7
-288.6
38.8
19.3
19.3
19.3
-30.7
-21.4
-18.5
61.7
29
24.1
-11
-1.9
1
1.4
0.7
0.6
10.2
-5
-3.1
0.1
-1.5
-0.5
4.3

income-statement-row.row.net-income

3619.63619.633222342.1
2711.7
1176.8
2096.9
263.5
-112.1
-558.1
-738.6
-445
-107
29.6
-754.6
-641.6
-459.9
-391.3
-206.9
-203.4
-166.2
-196.8
-108.6
-66.2
-39.7
-41
-33.1
-19.8
-40
-21.5
-17.6
2
-8.5
-5.1
-4.3
Lignende aktier
Du er måske også interesseret i:
SRNE
Sorrento Therapeutics, Inc..
0.014 USD
NASDAQ
MRVI
Maravai LifeSciences Holdings, Inc..
8.8 USD
NASDAQ
CMRA
Comera Life Sciences Holdings, Inc..
0.03 USD
NASDAQ
GUBRA.CO
Gubra A/S.
296 DKK
CPH
T5O.DE
CytoTools AG.
0.468 EUR
XETRA
HBC.OL
Hofseth BioCare ASA.
2.04 NOK
OSL
6826.HK
Shanghai Haohai Biological Technology Co., Ltd..
42.05 HKD
HKSE
PPBT
Purple Biotech Ltd..
0.67 USD
NASDAQ

Ofte stillede spørgsmål

Hvad er Vertex Pharmaceuticals Incorporated (VRTX) samlede aktiver?

Vertex Pharmaceuticals Incorporated (VRTX) samlede aktiver er 22730200000.000.

Hvad er virksomhedens årlige omsætning?

Den årlige omsætning er 5001200000.000.

Hvad er virksomhedens profitmargin?

Virksomhedens profitmargin er 0.872.

Hvad er virksomhedens frie pengestrøm?

Det frie cash flow er 12.724.

Hvad er virksomhedens nettoprofitmargin?

Nettofortjenstmargenen er 0.367.

Hvad er firmaets samlede omsætning?

Den samlede omsætning er 0.385.

Hvad er Vertex Pharmaceuticals Incorporated (VRTX) nettoresultat (nettoindkomst)?

Nettoresultatet (nettoindkomsten) er 3619600000.000.

Hvad er virksomhedens samlede gæld?

Den samlede gæld er 808400000.000.

Hvad er tallet for driftsudgifter?

Driftsudgifterne er 4826600000.000.

Hvad er firmaets likviditet?

Virksomhedens likviditet er 10372300000.000.